Zentek Launches National Sampling Program for ZenGUARD(TM) Antimicrobial Surgical Masks
Zentek (NASDAQ:ZTEK, TSXV:ZEN) has announced a nationwide sampling program for its ZenGUARD™ Antimicrobial Surgical Masks in Canada, facilitated by Henry Schein Inc. The program targets dental professionals, with ZenGUARD™ masks to be included in product shipments to Henry Schein customers.
Key features of ZenGUARD™ masks include:
- Enhanced protection against infectious agents
- 99.9% elimination of bacteria
- Reduction of mask-related acne
- Superior filtration compared to standard ASTM Level 3 surgical masks
Zentek CEO Greg Fenton emphasized the importance of safety in dental practices and positioned ZenGUARD™ technology as the new standard for protection in this market segment.
Zentek (NASDAQ:ZTEK, TSXV:ZEN) ha annunciato un programma di campionamento a livello nazionale per le sue Maschere Chirurgiche Antimicrobiche ZenGUARD™ in Canada, facilitato da Henry Schein Inc. Il programma è rivolto ai professionisti dentali, con le maschere ZenGUARD™ incluse nelle spedizioni di prodotti ai clienti di Henry Schein.
Le principali caratteristiche delle maschere ZenGUARD™ includono:
- Protezione avanzata contro agenti infettivi
- Eliminazione del 99,9% dei batteri
- Riduzione dell'acne correlata alla maschera
- Filtrazione superiore rispetto alle maschere chirurgiche standard di livello ASTM 3
Il CEO di Zentek, Greg Fenton, ha sottolineato l'importanza della sicurezza nelle pratiche dentali e ha posizionato la tecnologia ZenGUARD™ come il nuovo standard di protezione in questo segmento di mercato.
Zentek (NASDAQ:ZTEK, TSXV:ZEN) ha anunciado un programa de muestreo a nivel nacional para sus Mascarillas Quirúrgicas Antimicrobianas ZenGUARD™ en Canadá, facilitado por Henry Schein Inc. El programa está dirigido a profesionales dentales, con las mascarillas ZenGUARD™ incluidas en los envíos de productos a los clientes de Henry Schein.
Las características clave de las mascarillas ZenGUARD™ incluyen:
- Protección mejorada contra agentes infecciosos
- Eliminación del 99,9% de las bacterias
- Reducción del acné relacionado con la mascarilla
- Filtración superior en comparación con las mascarillas quirúrgicas estándar de nivel ASTM 3
El CEO de Zentek, Greg Fenton, enfatizó la importancia de la seguridad en las prácticas dentales y posicionó la tecnología ZenGUARD™ como el nuevo estándar de protección en este segmento de mercado.
젠텍(Zentek) (NASDAQ:ZTEK, TSXV:ZEN)이 캐나다에서 제균 항균 수술용 마스크 젠가드™(ZenGUARD™)에 대한 전국 샘플링 프로그램을 헨리 샤인(Henry Schein Inc.)의 주도로 발표했습니다. 이 프로그램은 치과 전문의를 목표로 하며, 헨리 샤인 고객에게 제품 배송 시 젠가드™ 마스크가 포함됩니다.
젠가드™ 마스크의 주요 특징은 다음과 같습니다:
- 감염원에 대한 향상된 보호
- 99.9%의 박테리아 제거
- 마스크 관련 여드름 감소
- 표준 ASTM 레벨 3 수술용 마스크에 비해 우수한 필터링 성능
젠텍의 CEO인 그렉 펜튼(Greg Fenton)은 치과 진료에서의 안전의 중요성을 강조하며, 젠가드™ 기술을 이 시장 세그먼트의 새로운 보호 표준으로 자리매김했습니다.
Zentek (NASDAQ:ZTEK, TSXV:ZEN) a annoncé un programme d'échantillonnage national pour ses Masques Chirurgicaux Antimicrobiens ZenGUARD™ au Canada, facilité par Henry Schein Inc. Le programme vise les professionnels dentaires, avec les masques ZenGUARD™ inclus dans les expéditions de produits aux clients de Henry Schein.
Les principales caractéristiques des masques ZenGUARD™ incluent :
- Protection renforcée contre les agents infectieux
- Élimination de 99,9 % des bactéries
- Réduction de l'acné liée aux masques
- Filtration supérieure par rapport aux masques chirurgicaux standard ASTM de niveau 3
Greg Fenton, PDG de Zentek, a souligné l'importance de la sécurité dans les pratiques dentaires et a positionné la technologie ZenGUARD™ comme la nouvelle norme de protection dans ce segment de marché.
Zentek (NASDAQ:ZTEK, TSXV:ZEN) hat ein landesweites Sampling-Programm für seine ZenGUARD™ Antimikrobiellen Chirurgischen Masken in Kanada angekündigt, das von Henry Schein Inc. unterstützt wird. Das Programm richtet sich an Zahnmedizin-Profis, wobei die ZenGUARD™-Masken in die Produktlieferungen an die Kunden von Henry Schein aufgenommen werden.
Die Hauptmerkmale der ZenGUARD™-Masken umfassen:
- Erweiterter Schutz vor infektiösen Erregern
- 99,9% Eliminierung von Bakterien
- Verringerung maskenbedingten Akne
- Überlegene Filtration im Vergleich zu standardmäßigen chirurgischen Masken der ASTM Stufe 3
Greg Fenton, CEO von Zentek, betonte die Bedeutung von Sicherheit in der zahnärztlichen Praxis und positionierte die ZenGUARD™-Technologie als neuen Standard für den Schutz in diesem Marktsegment.
- Launch of nationwide sampling program for ZenGUARD™ Antimicrobial Surgical Masks
- Partnership with Henry Schein Inc. for product distribution
- Potential exposure to nearly all Henry Schein customers across Canada
- Superior product features compared to standard ASTM Level 3 surgical masks
- None.
The partnership with Henry Schein Inc. to distribute ZenGUARD™ Antimicrobial Surgical Masks across Canada is a strategic move for Zentek. Henry Schein is a well-established distributor in the dental industry, which means this initiative could significantly increase the market penetration of ZenGUARD™ masks. This distribution strategy can help Zentek rapidly scale its product exposure and adoption. For retail investors, it’s essential to note that securing a partnership with a major distributor like Henry Schein could potentially lead to increased sales and revenue if the product gains traction in the market.
ZenGUARD™ Antimicrobial Surgical Masks have a unique value proposition with their ability to eliminate 99.9% of bacteria, which is a significant advantage over standard masks. This feature is particularly relevant in medical and dental settings where long-term mask wear is common. The claim that these masks can reduce mask-related acne could appeal to dental professionals and patients alike. From a clinical perspective, if these claims are backed by strong scientific evidence, it could lead to widespread adoption among healthcare providers, thereby boosting Zentek’s market share in the medical supplies sector.
This move could have positive financial implications for Zentek. By partnering with Henry Schein, a major distributor, Zentek is leveraging an established network to reach a broader audience. If the masks are well-received, it could result in significant revenue growth. Additionally, successful adoption in Canada could serve as a proof-of-concept for launching similar programs in other countries, potentially expanding Zentek’s market further. Investors should keep an eye on sales figures in the coming quarters to gauge the success of this initiative and its impact on Zentek’s financial performance.
GUELPH, ON / ACCESSWIRE / July 24, 2024 / Zentek Ltd. ("Zentek" or the "Company") (NASDAQ:ZTEK)(TSXV:ZEN), an intellectual property development and commercialization company announces that it will embark on a Canada-wide sampling program for dental professionals facilitated by Henry Schein Inc. ("Henry Schein") that will see ZenGUARD™ Antimicrobial Surgical Masks included in product shipments to Henry Schein customers.
In addition to offering dental practitioners and their patients a surgical mask with better protection against infectious agents, ZenGUARD™ Antimicrobial Surgical Masks are also proven to eliminate
"The safety of staff and patients in dental practices is paramount, and surgical masks play a crucial role as they serve as a primary barrier against the transmission of infectious agents, including bacteria, viruses, and other pathogens. With the ability for ZenGUARD™ Antimicrobial Surgical Masks to eliminate bacteria and filter more virus particles compared to standard ASTM Level 3 surgical masks, we believe that this technology should be the new standard of protection for this incredibly important market segment," said Greg Fenton, Zentek CEO.
About Zentek Ltd.
Zentek is an ISO 13485:2016 certified intellectual property technology company focused on the research, development and commercialization of novel products seeking to give the Company's commercial partners a competitive advantage by making their products better, safer, and greener.
Zentek's patented technology platform ZenGUARD™, is shown to have 99-per-cent anti-microbial activity and to significantly increase the viral filtration efficiency for surgical masks and aims to do the same for HVAC (heating, ventilation, and air conditioning) systems. Zentek's ZenGUARD™ production facility is in Guelph, Ontario.
For further information on Zentek:
investorrelations@zentek.com
Ryan Shacklock
Senior VP, Strategy & Business Development
Email: rshacklock@zentek.com
Phone: 306-270-9610
To find out more about Zentek, please visit our website at www.Zentek.com. A copy of this news release and all material documents in respect of the Company may be obtained on Zentek's SEDAR+ profile at http://www.sedarplus.ca/.
Forward-Looking Statements
This news release contains forward-looking statements. Since forward-looking statements address future events and conditions, by their very nature they involve inherent risks and uncertainties. Although Zentek believes that the assumptions and factors used in preparing the forward-looking information in this news release are reasonable, undue reliance should not be placed on such information, which only applies as of the date of this news release, and no assurance can be given that such events will occur in the disclosed time frames or at all. Zentek disclaims any intention or obligation to update or revise any forward-looking information, whether as a result of new information, future events or otherwise, other than as required by law.
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
SOURCE: Zentek
View the original press release on accesswire.com
FAQ
What is Zentek's new product sampling program for ZenGUARD™ Antimicrobial Surgical Masks?
What are the key features of Zentek's ZenGUARD™ Antimicrobial Surgical Masks?
How does Zentek (ZTEK) plan to introduce ZenGUARD™ masks to the dental market?